Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004; 26:302–309.PubMed
Al-Zayer MA, Straffon LH, Feigal RJ, Welch KB. Indirect pulp treatment of primary posterior teeth; a retrospective study. Pediatr Dent 2003; 25:29–36.PubMed
Alacam A. Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde-calcium hydroxide and glutaraldehyde-zinc oxide eugenol on succedaneous teeth. J Pedod 1989; 18:123–132.
Araujo FB, Ely LB, Pergo AM, Pesce HF. A clinical evaluation of 2% buffered glutaraldehyde in pulpotomies of human deciduous teeth: a 24-month study. Braz Dent 1995; 6:41–44.
Auerbach C, Moutschen-Damen M, Moutschen M. Genetic and cytogenetical effects of formaldehyde and related compounds. Mutat Res 1977; 39:317–361.PubMedCrossRef
Berger JE. Pulp tissue reaction to formocresol and zinc-oxide eugenol. J Dent Child 1965; 32:13–27.
Bjorndal L, Larsen T, Thylstrup A. A clinical and microbiological study on deep carious lesions during stepwise excavation using long treatment intervals. Caries Research 1997; 31: 411–417.PubMedCrossRef
Bjorndal L, Thylstrup A. A practice-based study on stepwise excavation of deep carious lesions in permanent teeth. Community Dentistry and Oral Epidemiology 1998:26; 122–128.PubMedCrossRef
Block RM, Lewis RD, Sheats JB, Fauley J. Cell-mediated immune response to dog pulp tissue altered by formocresol within the root canal. J Endod 1977; 3:424–430.PubMedCrossRef
Block RM, Lewis RD, Sheats JB, Burke SG. Antibody formation to dog pulp tissue altered by formocresol within the root canal. Oral Surg 1978; 45:282–292.PubMedCrossRef
Burnett S, Walker J. Comparison of ferric sulfate, formocresol and a combination of ferric sulfate/formocresol in primary tooth vital pulpotomies: a retrospective radiographic survey. J Dent Child 2002; 69: 44–48.
Casas MJ, Layung MA, Kenny DJ, Johnston DH, Judd PL. Two-year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy.Pediatr Dent 2003; 25: 97–102.PubMed
Casas MJ, Kenny DJ, Johnston DH, Judd PL. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent 2004; 26:44–48.PubMed
Casas M J, Kenny DJ, Johnston DH, Judd PL et al. Outcomes of vital primary incisor ferric sulfate pulpotomy and root canal therapy. J Can Dent Assoc 2004; 70: 34–38.PubMed
Curzon MEJ, Toumba KJ. Restoration of primary teeth: Criteria for assessment of the literature 2006; Eur Arch Paediatr Dent 7, special issue.
Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent 2003; 12:177–182.CrossRef
Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs formocresol in pulpotomized primary molars: A preliminary report. Pediatr Dent 2001;23:15–18.PubMed
Elliot RD, Roberts MW, Burkes J, Phillips C. Evaluation of carbon dioxide laser on vital human primary pulp tissue. Pediatr Dent 1999; 21:327–331.
Fadavi S, Anderson AW. A comparison of the pulpal response to freeze-dried bone, calcium hydroxide, and zinc oxide-eugenol in primary teeth in two cynomolgus monkeys. Pediatr Dent 1996; 18:52–56.PubMed
Falster CA, Araujo FB, Straffon LH, Nor JE. Indirect pulp treatment: in vivo outcomes of am adhesive resin system vs calcium hydroxide for protection of the dentin-pulp complex. Pediatr Dent 2002; 24: 241–248.PubMed
Farooq NS, Coll JA, Kuwabara A, Shelton P. Success rates of formocresol pulpotomy and indirect pulp treatmentof deep dentinal caries in primary teeth. Pediatr Dent 2000; 22: 278–286.PubMed
Farsi N, Alamoudi N, Balto K, Mushayt A. Success of minerals trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent 2005; 29:307–311.PubMed
Fei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 1991; 13:327–332.PubMed
Fishman SA, Udin RD, Good DL, Rodef F. Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatr Dent 1996; 18:385–390.PubMed
Fuks AB, Bimstein E. Clinical evaluation of diluted formocresol pulpotomy in primary teeth of school children. Pediatr Dent 1981; 3:321–324.PubMed
Fuks AB, Bimstein E, Klein H, Guelmann M. Assessment of a 2%buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren. J Dent Child 1990; 57:371–375.
Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long term follow-up. Pediatr Dent 1997; 19:327–330.PubMed
Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002; 3:115–120.PubMed
Fuks AB: Pulp Therapy For The Primary Dentition, In Pediatric Dentistry, Infancy Through Adolescence. 2005; J R Pinkham. Elsevier, 11830 Westline Industrial Drive, St. Louis, MO—4th Edition, 375–393
Gruythuysen RJ, Weerheijm KL. Calcium hydroxide pulpotomy with a light-cured cavity-sealing material after two years. J Dent Child 1997; 64:251–253.
Guelmann M, Fair J, Turner C, Courts FJ. The success of emergency pulpotomies in primary molars. Pediatr Dent 2002; 24:217–220.PubMed
Guelmann M, MIlwain MF, Primosch RE. Radiographic assessment of primary molar pulpotomies restored with resin-based materials. Pediatr Dent 2005; 27:24–27.PubMed
Holan G, Fuks AB, Keltz N. Success rate of formocresol pulpotomy in primary molars restored with stainless steel crowns vs amalgam. Pediatr Dent 2002; 24:212–216.PubMed
Holan G, Eidelman E, Fuks AB. Lon-term evaluation of pulpotomy in primary molars using mineral Trioxide Aggregate and formocresol. Pediatr Dent 2005
Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, et al. Effectiveness of 4 pulpotomy techniques-randomized controlled trial.J Dent Res 2005; 84:1144–1148.PubMedCrossRef
Ibrevic H, Al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent 2000; 24:269–272.
International Agency for Research on Cancer. Press release no. 153. 15 June 2004. [WWW document.] URL
Judd PL, Kenny DJ. Formocresol concerns: A review. J Can Dent Assoc 1987; 53:401–404.PubMed
Kalaskar RR, Damle SG. Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in primary molars. J Indian Soc Pedod Prev Dent 2004; 22:24–29.PubMed
Koch G, Nyborg H. Correlation between clinical and histological indications for pulpotomy of deciduous teeth. J Int Assoc Dent Child 1970; 1:3–10.PubMed
Loh A, O’Hoy P, Tran X, et al. Evidence-based assessment. Evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatric Dentistry 2004; 26:401–409.PubMed
Magnusson BO. Therapeutic pulpotomies in primary molars with the formocresol technique. Acta Odontol Scand 1978; 36:157–165.PubMedCrossRef
Markovic D, Zibojinovic V, Bucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent 2005; 6:133–138.PubMed
Maroto M, Barberia E, Planells P, Garcia Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent 2005; 18:151–154.PubMed
Mejare I. Pulpotomy of primary molars with coronal or total pulpitis using formocresol technique. Scand J Dent Res 1979; 87:208–216.PubMed
Mertz-Fairhurst EJ, Curtis JW Jr, Ergle JW, Rueggeberg FA, Adair SM. Cariostatic and ultraconservative sealed restorations: nine-year results among children and adults. J Dent Child 1995; 62:97–107.
Mertz-Fairhurst EJ et al. Ultraconservative and cariostatic sealed restorations: results at year 10. J Am Dent Assoc 1998; 129:55–66.PubMed
Morawa AP, Straffon LH, Han SS, Corpron RE. Clinical evaluation of pulpotomies using dilute formocresol. J Dent Child 1975; 42:28–31.
Myers DR, Shoaf HK, Dirksen TR, Pashley DH, Whitford GM, Reynolds KE. Distribution of 14c formaldehyde after pulpotomy with formocresol. J Am Dent Assoc 1978; 96:805–813.PubMed
Naik S, Hegde AM. Mineral trioxide aggregate as a pulpotomy agent in primary molars: An in vivo study. J Indian Soc Pedod Prev Dent 2005; 23:13–16.PubMedCrossRef
Nadine G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth. Cochraine Database Syst Rev 2003; (1):CD0033220. Review.
Nakashima M. The induction of reparative dentine in the amputated dental pulp of the dog by bone morphogenetic protein. Arch Oral Biol 1990;35:493–497.PubMedCrossRef
Nakashima M. Induction of dentine formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and 4. J Dent Res 1994;73:1515–1522.PubMed
Prakash C, Chandra S, Jaiswal JN. Formocresol and pulpotomies in primary teeth. J Pedod 1989; 13:314–322.PubMed
Primosch, RE, Glom TA, Jerrell RG. Primary tooth pulp therapy as taught in predoctoral pediatric dental programs in the United States. Pediatr Dent 1997; 19:118–122.PubMed
Pruhs RJ, Olen GA, Sharma PS. Relationship between formocresol pulpotomies on primary teeth and enamel defects on their permanent successors. J Am Dent Assoc 1977; 94:698–700.PubMed
Redig DF. A comparison and evaluation of two formocresol pulpotomy technics utilizing “Buckley’s “formocresol. J Dent Child 1968; 35: 22–29.PubMed
Rivera N, Reyes E, Mazzaoui S, Moron A. Pulpal therapy for primary teeth: formocresol vs electrosurgery: a clinical study. J Dent child 2003; 70:71–73.
Rutherford RB, Wahle J, Tucker M, Roger D, Charette M. Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol 1993; 38:571–576.PubMedCrossRef
Saltzman B, Sigal M, Clokie C, Rukavina J, et al. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy. Int J Paediatr Dent 2005;15: 437–447.PubMedCrossRef
Sasaki H, Ogawa T, Koreeda M, Ozaki T, et al. Electrocoagulation extends the indication of calcium hydroxide pulpotomy in the primary dentition. J Clin Pediatr Dent 2002; 26:275–277.PubMed
Schroder U. A 2-year follow-up of primary molars, pulpotomized with a gentle technique and capped with calcium hydroxide. Scand J Dent Res 1978; 86:273–278.PubMed
Shumayrikh NM, Adenubi JO. Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endod Dent Traumatol 1999; 15:259–264.PubMedCrossRef
Smith NL, Seale NS, Nunn ME. Ferric sulfate pulpotomy in primary molars: a retrospective study. Pediatr Dent 2000; 22:192–199.PubMed
Srinivasan V, Patchett CL, Waterhouse JP. Is there life after Buckley’s formocresol? Part I—A narrative review of alternative interventions and materials. Int J Paediatr Dent 2006; 16:117–135.PubMedCrossRef
Straffon LH, Loos P. The indirect pulp cap: a review and commentary. J Israel Dent Assoc 2000; 17: 7–14.
Stange DM, Seale NS, Nunn ME, Strange M. Outcome of formocresol/ZOE sub-base pulpotomies utilizing alternative radiographic success criteria. Pediatr Dent 2001; 23:331–336.
Sun HW, Feigal RJ, Messer HH. Cytotoxicity of glutaraldehyde and formaldehyde in relation to time of exposure and concentration. Pediatr Dent 1990; 12:303–307.PubMed
Thompson KS, Seale NS, Nunn ME, Huff G. Alternative method of hemorrhage control in full strength formocresol pulpotomy. Pediatr Dent 2001; 23:217–222.PubMed
Vargas KG, Packham B. Radiographic success of ferric sulfate and formocresol pulpotomies in relation to early exfoliation. Pediatr Dent 2005; 27:233–237.PubMed
Vij R, Coll JA, Shelton P, Farooq NS. Caries control and other variables associated with success of primary molar vital pulp therapy. Pediatr Dent 2004; 26:214–220.PubMed
Waterhouse PJ, Nunn JH, Whitworth JM, Soames JV. Primary molar pulp therapy—histological evaluation of failure. Int J Paediatr Dent 2000; 10:313–321.PubMedCrossRef
Waterhouse PJ, Nunn JH, Whitworth JM. Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. Int J Paediatr Dent 2002; 12:116–123.PubMedCrossRef